Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP). Material Number: 11097543. Recall
Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP). Material Number: 11097543.
FDA recall Class II
Ongoing
FDA lists this Class II recall for Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP). Material Number: 11097543.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2542-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Aug 11, 2025
- FDA report date
- Sep 17, 2025
- Quantity in commerce
- 11,811 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP). Material Number: 11097543.
Affected model & UDI checker
Search the exact identifiers published for Z-2542-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP). Material Number: 11097543. | Check source notice | 00630414279206 |
FDA code information
Material Number: 11097543. Test Code: UCFP. UDI-DI: 00630414279206. All lot numbers.
Why was this product recalled?
Potential for falsely depressed patient, quality control (QC), and/or calibration results or delayed results.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Siemens Healthcare Diagnostics, Inc. take?
Siemens Healthcare Diagnostics notified consignees on about 08/11/2025 via letter. Customers were instructed to perform QC on each well, track additional reagent consumption (number of tests) to report to Siemens Healthineers for future reimbursement/credit, review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable, and retain this letter with your laboratory records and forward this letter to those who may have received this product. Additionally, consignees were instructed to complete and return the Field Correction Effectiveness Check Form.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2542-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology